Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C29H23F2N3O2 |
| Molecular Weight | 483.5086 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C(F)=C1)C2=CC=C(OCCOC3=CC=C(CN4C=CN=C4)C=C3)N=C2C5=CC=CC=C5
InChI
InChIKey=BMSLEFJNHPVCLR-UHFFFAOYSA-N
InChI=1S/C29H23F2N3O2/c30-23-8-11-25(27(31)18-23)26-12-13-28(33-29(26)22-4-2-1-3-5-22)36-17-16-35-24-9-6-21(7-10-24)19-34-15-14-32-20-34/h1-15,18,20H,16-17,19H2
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| PPA250 [3-(2,4-difluorophenyl)-6-[2-[4-(1H-imidazol-1-ylmethyl) phenoxy]ethoxy]-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of chronic arthritis. | 2002-10 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
T30P6RJ258
Created by
admin on Mon Mar 31 22:33:55 GMT 2025 , Edited by admin on Mon Mar 31 22:33:55 GMT 2025
|
PRIMARY | |||
|
9805308
Created by
admin on Mon Mar 31 22:33:55 GMT 2025 , Edited by admin on Mon Mar 31 22:33:55 GMT 2025
|
PRIMARY | |||
|
385413-62-7
Created by
admin on Mon Mar 31 22:33:55 GMT 2025 , Edited by admin on Mon Mar 31 22:33:55 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
